Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 108401-108450 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT06490159
Predicting Peripheral Neuropathy of Paclitaxel for Gastric Cancer
N/ARecruiting
150 participants
Started: Oct 1, 2018 · Completed: Jun 18, 2026
4 conditions1 sponsor1 location
NCT03826433
hUC Mesenchymal Stem Cells (19#iSCLife®-LC) in the Treatment of Decompensated Hepatitis b Cirrhosishepatitis b Cirrhosis
PHASE1Recruiting
20 participants
Started: Oct 1, 2018 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04190420
The Transition From Hypertension to Hypertensive Heart Disease and Heart Failure, the PREFERS Hypertension Study
N/AEnrolling by invitation
310 participants
Started: Oct 1, 2018 · Completed: Dec 31, 2025
4 conditions1 sponsor1 location
NCT02860091
Blood Ropivacaine Concentrations Following Chest Wall Nerve Block Continuous Infusion
N/AActive, not recruiting
26 participants
Started: Oct 1, 2018 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT03694691
Developing Viability Index for Machine Perfused Livers
NARecruiting
60 participants
Started: Oct 1, 2018 · Completed: Jun 1, 2025
1 condition2 sponsors1 location
NCT06235424
Del Nido Versus HTK Cardioplegia in Adult Aortic Valve Replacement
PHASE4Active, not recruiting
100 participants
Started: Oct 1, 2018 · Completed: Sep 24, 2024
3 conditions1 sponsor1 location
NCT03770923
Effect of Some Drugs on Rheumatoid Arithritis Activity
PHASE3Recruiting
75 participants
Started: Oct 1, 2018 · Completed: Oct 31, 2027
1 condition1 sponsor1 location
NCT03713268
Intraoperative OCT Guidance of Intraocular Surgery II
N/ARecruiting
262 participants
Started: Sep 30, 2018 · Completed: May 31, 2027
10 conditions2 sponsors1 location
NCT03706014
Innovative Family Prevention With Latino Siblings in Disadvantaged Settings
NAActive, not recruiting
270 participants
Started: Sep 29, 2018 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT04188678
Resiliency in Older Adults Undergoing Bone Marrow Transplant
N/AActive, not recruiting
126 participants
Started: Sep 28, 2018 · Completed: Oct 30, 2025
6 conditions3 sponsors1 location
NCT03651154
Hypovolemic Phlebotomy to Reduce Blood Transfusions in Major Hepatic Resections
NAActive, not recruiting
440 participants
Started: Sep 28, 2018 · Completed: Jan 31, 2026
4 conditions1 sponsor4 locations
NCT03667599
A Phase 2 Study of Home Care Following Autologous Hematopoietic Stem Cell Transplantation
NARecruiting
150 participants
Started: Sep 28, 2018 · Completed: Jan 30, 2027
1 condition1 sponsor1 location
NCT04850079
EHR Precision Drug Treatment in Neonates
N/AActive, not recruiting
200 participants
Started: Sep 28, 2018 · Completed: Dec 31, 2024
2 conditions2 sponsors1 location
NCT03671889
ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's Disease
NARecruiting
150 participants
Started: Sep 28, 2018 · Completed: Dec 31, 2025
1 condition1 sponsor10 locations
NCT03659916
Long Term Safety & Efficacy Study Evaluating The Effect of A4250 in Children With PFIC
PHASE3Active, not recruiting
116 participants
Started: Sep 28, 2018 · Completed: Oct 10, 2025
1 condition1 sponsor41 locations
NCT03671226
Preference of Room Setting and Waiting Time in Patients With Advanced, Locally Advanced, or Metastatic Cancer and Their Caregivers Who Are Seen in the Outpatient Supportive/Palliative Care Center
NAActive, not recruiting
406 participants
Started: Sep 28, 2018 · Completed: Dec 31, 2027
4 conditions2 sponsors1 location
NCT03711175
The Influence of Repairing the Sub-scapularis on Outcomes After Reverse Arthroplasty
NAEnrolling by invitation
200 participants
Started: Sep 28, 2018 · Completed: Dec 31, 2028
1 condition1 sponsor4 locations
NCT05566093
EUS-FNI for Nonfunctional Pancreatic Neuroendocrine Tumors
NARecruiting
20 participants
Started: Sep 28, 2018 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT03568188
Efficacy Evaluation of Focused HIFU (High Intensity Focused Ultrasound) Therapy in Patients With Localized Intermediate Risk Prostate Cancer
PHASE2Active, not recruiting
170 participants
Started: Sep 28, 2018 · Completed: Sep 28, 2025
1 condition1 sponsor15 locations
NCT03609944
SpHincterotomy for Acute Recurrent Pancreatitis
NAActive, not recruiting
181 participants
Started: Sep 27, 2018 · Completed: Aug 31, 2025
5 conditions2 sponsors21 locations
NCT03634540
A Trial of Belzutifan (PT2977, MK-6482) in Combination With Cabozantinib in Patients With Clear Cell Renal Cell Carcinoma (ccRCC) (MK-6482-003)
PHASE2Active, not recruiting
118 participants
Started: Sep 27, 2018 · Completed: Feb 26, 2027
9 conditions1 sponsor10 locations
NCT03682068
Study of Durvalumab Given With Chemotherapy, Durvalumab in Combination With Tremelimumab Given With Chemotherapy, or Chemotherapy in Patients With Unresectable Urothelial Cancer
PHASE3Active, not recruiting
1,246 participants
Started: Sep 27, 2018 · Completed: Apr 29, 2026
2 conditions1 sponsor222 locations
NCT03718260
PSMA-PET Registry for Recurrent Prostate Cancer
NARecruiting
3,070 participants
Started: Sep 27, 2018 · Completed: Dec 31, 2025
1 condition3 sponsors6 locations
NCT03703297
Study of Durvalumab + Tremelimumab, Durvalumab, and Placebo in Limited Stage Small-Cell Lung Cancer in Patients Who Have Not Progressed Following Concurrent Chemoradiation Therapy
PHASE3Active, not recruiting
730 participants
Started: Sep 27, 2018 · Completed: Mar 5, 2026
1 condition1 sponsor183 locations
NCT03620058
CART22 Alone or in Combination With huCART19 for ALL
PHASE1Active, not recruiting
23 participants
Started: Sep 27, 2018 · Completed: Jan 31, 2036
2 conditions1 sponsor1 location
NCT03660631
Dissemination of the Cardiovascular Risk Service
NAActive, not recruiting
542 participants
Started: Sep 27, 2018 · Completed: Dec 30, 2024
2 conditions1 sponsor14 locations
NCT03723655
A Long-Term Safety Extension Study of Mavacamten in Adults Who Have Completed MAVERICK-HCM or EXPLORER-HCM
PHASE2/PHASE3Active, not recruiting
282 participants
Started: Sep 27, 2018 · Completed: Jan 16, 2026
3 conditions1 sponsor68 locations
NCT03660826
Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib Alone
PHASE2Active, not recruiting
288 participants
Started: Sep 27, 2018 · Completed: Jan 24, 2026
6 conditions2 sponsors766 locations
NCT03838926
Tolerability Study of Trichostatin A In Subjects With Relapsed or Refractory Hematologic Malignancies
PHASE1Recruiting
42 participants
Started: Sep 27, 2018 · Completed: Dec 31, 2025
1 condition1 sponsor11 locations
NCT03566043
CAMPSIITE™ RGX-121 Gene Therapy in Subjects With MPS II (Hunter Syndrome)
PHASE2/PHASE3Active, not recruiting
48 participants
Started: Sep 27, 2018 · Completed: Aug 31, 2025
1 condition1 sponsor5 locations
NCT03378934
Anti-platelet Effect of Berberine in Patients After Percutaneous Coronary Intervention
PHASE4Recruiting
64 participants
Started: Sep 26, 2018 · Completed: Aug 31, 2025
2 conditions1 sponsor1 location
NCT03667820
Study of Osimertinib and Stereotactic Ablative Radiation (SABR) in EGFR Mutant NSCLC
PHASE2Active, not recruiting
41 participants
Started: Sep 26, 2018 · Completed: Sep 30, 2025
1 condition2 sponsors2 locations
NCT03716128
Diagnosis of Renal Osteodystrophy in Patients With Reduced Renal Function
N/ARecruiting
40 participants
Started: Sep 26, 2018 · Completed: Oct 31, 2027
1 condition3 sponsors1 location
NCT03659227
Drug Reactions Sampling (COLLECTIONTOXIDERMIES)
N/ARecruiting
500 participants
Started: Sep 26, 2018 · Completed: Sep 25, 2028
8 conditions1 sponsor1 location
NCT03507413
Metformin Therapy in Non-diabetic AAA Patients
PHASE2/PHASE3Active, not recruiting
170 participants
Started: Sep 26, 2018 · Completed: May 1, 2024
1 condition2 sponsors1 location
NCT03547700
Study of Ixazomib and Romidepsin in Peripheral T-cell Lymphoma (PTCL)
PHASE1/PHASE2Active, not recruiting
11 participants
Started: Sep 26, 2018 · Completed: Jul 31, 2021
1 condition3 sponsors7 locations
NCT03656835
Nanochip Technology in Monitoring Treatment Response and Detecting Relapse in Participants With Diffuse Large B-Cell Lymphoma
NAActive, not recruiting
73 participants
Started: Sep 26, 2018 · Completed: Nov 19, 2025
4 conditions1 sponsor1 location
NCT03793114
Screening and Stimulation Testing for Residual Secretion of Adrenal Steroid Hormones in Autoimmune Addison's Disease
NAActive, not recruiting
200 participants
Started: Sep 26, 2018 · Completed: Dec 31, 2025
1 condition3 sponsors3 locations
NCT03286335
Local Control, Quality of Life and Toxicities in Adults With Benign or Indolent Brain Tumors Undergoing Proton Radiation Therapy
NARecruiting
100 participants
Started: Sep 26, 2018 · Completed: Sep 30, 2027
1 condition1 sponsor1 location
NCT03326336
Dose-escalation Study to Evaluate the Safety and Tolerability of GS030 in Subjects With Retinitis Pigmentosa
PHASE1/PHASE2Active, not recruiting
10 participants
Started: Sep 26, 2018 · Completed: Oct 26, 2027
1 condition1 sponsor3 locations
NCT05329636
Auto Fecal Microbial Transplant Post Helicobacter Pylori Antibiotic Therapy
PHASE1/PHASE2Recruiting
30 participants
Started: Sep 26, 2018 · Completed: Jul 1, 2026
1 condition2 sponsors1 location
NCT03620786
HIFU for Focal Ablation of Prostate Tissue: An Observational Study
N/ARecruiting
100 participants
Started: Sep 26, 2018 · Completed: Jan 31, 2028
1 condition1 sponsor1 location
NCT03671018
A Study to Evaluate the Safety and Efficacy of Mosunetuzumab (BTCT4465A) in Combination With Polatuzumab Vedotin in B-Cell Non-Hodgkin Lymphoma
PHASE1/PHASE2Active, not recruiting
422 participants
Started: Sep 25, 2018 · Completed: Jul 20, 2025
1 condition1 sponsor29 locations
NCT03622606
Development and Validation of a Language Screening Test in Acute Right Hemispheric Strokes
NAActive, not recruiting
400 participants
Started: Sep 25, 2018 · Completed: Oct 31, 2024
1 condition2 sponsors2 locations
NCT03556839
Platinum Chemotherapy Plus Paclitaxel With Bevacizumab and Atezolizumab in Metastatic Carcinoma of the Cervix
PHASE3Active, not recruiting
410 participants
Started: Sep 25, 2018 · Completed: Aug 31, 2025
1 condition10 sponsors72 locations
NCT04174157
Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
N/ARecruiting
700 participants
Started: Sep 25, 2018 · Completed: Jun 30, 2038
1 condition1 sponsor99 locations
NCT03472768
The Impact of Age-dependent Haptoglobin Deficiency on Plasma Free Hemoglobin Levels During Extracorporeal Membrane Oxygenation Support
N/AActive, not recruiting
90 participants
Started: Sep 25, 2018 · Completed: Sep 30, 2024
1 condition1 sponsor1 location
NCT04149600
Identification of Genetic Causes of Calcific Aortic Valve Disease
N/AActive, not recruiting
1,000 participants
Started: Sep 25, 2018 · Completed: Jun 30, 2027
9 conditions2 sponsors1 location
NCT03573401
Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Superficial Basal Cell Carcinoma (sBCC) With Photodynamic Therapy (PDT).
PHASE3Active, not recruiting
187 participants
Started: Sep 25, 2018 · Completed: Feb 28, 2029
1 condition1 sponsor18 locations
NCT03624660
Dose-Escalated Proton Radiation Therapy for High-Risk Prostate Cancer
NAActive, not recruiting
100 participants
Started: Sep 24, 2018 · Completed: Sep 30, 2028
1 condition1 sponsor1 location